Ownership history in GEODE CAPITAL MANAGEMENT, LLC · 9 quarters on record
This page tracks every 13F SEC filing in which GEODE CAPITAL MANAGEMENT, LLC reported a position in NEUROSENSE THERAPEUTICS LTD (NRSN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 15,870 | — | 0% | 0.00% | $12K | $0.77 |
| 2025 Q3 | UNCHANGED | 15,870 | — | 0% | 0.00% | $20K | $1.25 |
| 2025 Q2 | UNCHANGED | 15,870 | — | 0% | 0.00% | $30K | $1.89 |
| 2025 Q1 | UNCHANGED | 15,870 | — | 0% | 0.00% | $15K | $0.93 |
| 2024 Q4 | ADDED | 15,870 | +3,907 | +32.7% | 0.00% | $19K | $1.20 |
| 2024 Q3 | UNCHANGED | 11,963 | — | 0% | 0.00% | $15K | $1.27 |
| 2024 Q2 | UNCHANGED | 11,963 | — | 0% | 0.00% | $13K | $1.12 |
| 2024 Q1 | UNCHANGED | 11,963 | — | 0% | 0.00% | $22K | $1.82 |
| 2023 Q4 | INITIATED | 11,963 | — | — | 0.00% | $9K | — |
As of 2025 Q4 — sorted by position size